Ravi Kanth Kamlekar

Ravi Kanth Kamlekar

Auto-generated profile, based on publicly available information

Ravi Kanth Kamlekar

School of Chemistry, University of Hyderabad, Hyderabad 500 046, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2013 in Nature
Verified
Journal Article
Open access
PDF file
DSDhirendra K Simanshu
Dhirendra K Simanshu
RKRavi Kanth Kamlekar
Ravi Kanth Kamlekar
DWDayanjan S. Wijesinghe
Dayanjan S. Wijesinghe
XZXianqiong Zou
Xianqiong Zou
XZXiuhong Zhai
Xiuhong Zhai
DPDinshaw J. Patel
Dinshaw J. Patel
A human lipid transfer protein (GLTPD1, named here CPTP) is shown to regulate eicosanoid production by mediating the intermembrane transfer of the phosphorylated sphingolipid ceramide-1-phosphate through a non-vesicular transport mechanism elucidated by structural, functional and biological data. The bioactive signalling lipid ceramide-1-phosphate (C1P) regulates diverse processes ranging from growth and survival to pro-inflammatory responses. In this study, Dinshaw Patel and colleagues address how C1P is transported to specific sites in the cell. A novel lipid transfer protein called ceramide-1-phosphate transfer protein (CPTP) was identified, and structural and functional studies reveal the mechanism by which C1P is transported from its site of synthesis in the Golgi complex to the plasma membrane. Phosphorylated sphingolipids ceramide-1-phosphate (C1P) and sphingosine-1-phosphate (S1P) have emerged as key regulators of cell growth, survival, migration and inflammation1,2,3,4,5. C1P produced by ceramide kinase is an activator of group IVA cytosolic phospholipase A2α (cPLA2α), the rate-limiting releaser of arachidonic acid used for pro-inflammatory eicosanoid production3,6,7,8,9, which contributes to disease pathogenesis in asthma or airway hyper-responsiveness, cancer, atherosclerosis and thrombosis. To modulate eicosanoid action and avoid the damaging effects of chronic inflammation, cells require efficient targeting, trafficking and presentation of C1P to specific cellular sites. Vesicular trafficking is likely10 but non-vesicular mechanisms for C1P sensing, transfer and presentation remain unexplored11,12. Moreover, the molecular basis for selective recognition and binding among signalling lipids with phosphate headgroups, namely C1P, phosphatidic acid or their lyso-derivatives, remains unclear. Here, a ubiquitously expressed lipid transfer protein, human GLTPD1, named here CPTP, is shown to specifically transfer C1P between membranes. Crystal structures establish C1P binding through a novel surface-localized, phosphate headgroup recognition centre connected to an interior hydrophobic pocket that adaptively expands to ensheath differing-length lipid chains using a cleft-like gating mechanism. The two-layer, α-helically-dominated ‘sandwich’ topology identifies CPTP as the prototype for a new glycolipid transfer protein fold13 subfamily. CPTP resides in the cell cytosol but associates with the trans-Golgi network, nucleus and plasma membrane. RNA interference-induced CPTP depletion elevates C1P steady-state levels and alters Golgi cisternae stack morphology. The resulting C1P decrease in plasma membranes and increase in the Golgi complex stimulates cPLA2α release of arachidonic acid, triggering pro-inflammatory eicosanoid generation.

1 September 2021 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
SPSukanya Arul Prakash
Sukanya Arul Prakash
RKRavi Kanth Kamlekar
Ravi Kanth Kamlekar

1 March 2019 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
MJMuruganandam Jayanthi
Muruganandam Jayanthi
SMSengan Megarajan
Sengan Megarajan
SSSiva Bala Subramaniyan
Siva Bala Subramaniyan
RKRavi Kanth Kamlekar
Ravi Kanth Kamlekar
AVAnbazhagan Veerappan
Anbazhagan Veerappan

1 February 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MSMegarajan Sengan
Megarajan Sengan
SSSiva Bala Subramaniyan
Siva Bala Subramaniyan
SPSukanya Arul Prakash
Sukanya Arul Prakash
RKRavikanth Kamlekar
Ravikanth Kamlekar
AVAnbazhagan Veerappan
Anbazhagan Veerappan

23 March 2015 in Quarterly Reviews of Biophysics
Verified
Journal Article
Closed access
PDF file
LMLucy Malinina
Lucy Malinina
DSDhirendra K Simanshu
Dhirendra K Simanshu
XZXiuhong Zhai
Xiuhong Zhai
VSValeria R. Samygina
Valeria R. Samygina
RKRaviKanth Kamlekar
RaviKanth Kamlekar
RBRhoderick E. Brown
Rhoderick E. Brown
Glycolipid transfer proteins (GLTPs) originally were identified as small (~24 kDa), soluble, amphitropic proteins that specifically accelerate the intermembrane transfer of glycolipids. GLTPs and related homologs now are known to adopt a unique, helically dominated, two-layer ‘sandwich’ architecture defined as the GLTP-fold that provides the structural underpinning for the eukaryotic GLTP superfamily. Recent advances now provide exquisite insights into structural features responsible for lipid headgroup selectivity as well as the adaptability of the hydrophobic compartment for accommodating hydrocarbon chains of differing length and unsaturation. A new understanding of the structural versatility and evolutionary premium placed on the GLTP motif has emerged. Human GLTP-motifs have evolved to function not only as glucosylceramide binding/transferring domains for phosphoinositol 4-phosphate adaptor protein-2 during glycosphingolipid biosynthesis but also as selective binding/transfer proteins for ceramide-1-phosphate. The latter, known as ceramide-1-phosphate transfer protein, recently has been shown to form GLTP-fold while critically regulating Group-IV cytoplasmic phospholipase A2activity and pro-inflammatory eicosanoid production.

15 August 2019 in ACS Omega
Verified
Journal Article
Open access
SSSiva Bala Subramaniyan
Siva Bala Subramaniyan
SVSanthosh Vijayakumar
Santhosh Vijayakumar
SMSengan Megarajan
Sengan Megarajan
RKRavi Kanth Kamlekar
Ravi Kanth Kamlekar
AVAnbazhagan Veerappan
Anbazhagan Veerappan
Herein, we report a new strategy based on jacalin functionalization to diminish the impact of biological fluids in the antibacterial applications of nanoparticles (NPs). Precoating pectin-capped copper sulfide NPs (pCuS) with bovine serum albumin produced a protein corona, which affects the antibacterial activity of pCuS. It was found that the minimum inhibitory concentration (MIC) increases fourfold because of the formation of the protein corona. Interestingly, the pCuS functionalized with jacalin enhance the targeting capabilities through bacterial cell surface glycan recognition with no interference from the protein corona. The MIC of pCuS decreases 16-fold on functionalization with jacalin. Mechanistic studies indicated that the pCuS functionalized with jacalin impede the protein corona interference and induce bacterial cell death by impairing the GSH/reactive oxygen species balance and disrupting the bacteria cell membrane. As a proof of concept, we used a bacteria-infected zebrafish animal model to demonstrate the interference of biological fluids in the antibacterial activity of NPs. Infected zebrafish treated with 1× MIC of pCuS failed to recover from the infection, but 4× MIC rescues the fish. The requirement of a high dose of NPs to treat the infection confirms the interference of biological fluids in nanotherapeutic applications. At the same time, the jacalin–pCuS complex rescues the infected fish at 16-fold lesser MIC. The results obtained from this study suggest that jacalin-mediated NP targeting may have broad implications in the development of future nanomedicine.